XML 54 R43.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Intangible Assets and Royalty Agreement - Summary of Intangible Assets (Details) - USD ($) |  | 9 Months Ended |  |  |
--- | --- | --- | --- | --- | ---
Jan. 29, 2007 | Sep. 30, 2016 | Jan. 13, 2016 | Dec. 31, 2015 | Jan. 05, 2011
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Total |  | $ 34,002,000 |  | $ 15,627,000 |
Less Accumulated amortization and impairment charges |  | (6,753,000) |  | (4,864,000) |
Net |  | 27,249,000 |  | 10,763,000 |
Stability Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Fair value of earn-out |  | $ 25,620,000 | $ 25,620,000 |  |
Licenses |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Weighted average amortization lives |  | 7 years |  |  |
Gross carrying value |  | $ 1,699,000 |  | 1,009,000 |
Licenses | Stability Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  | 690,000 |  |
Licenses | Shriners Hospitals for Children and University of South Florida Research Foundation, Inc. |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Acquisition price | $ 996,000 |  |  |  |
Maximum time of approval | 30 days |  |  |  |
Fair value of earn-out | $ 200,000 |  |  |  |
Contingent royalty to be paid to licensor | 3.00% |  |  |  |
Annual royalty payment, minimum | $ 50,000 |  |  |  |
Licenses | Surgical Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  |  |  | $ 13,000
Patents and know-how |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Weighted average amortization lives |  | 19 years |  |  |
Gross carrying value |  | $ 17,211,000 |  | 8,001,000 |
Patents and know-how | Stability Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  | 9,170,000 |  |
Patents and know-how | Surgical Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  |  |  | 7,690,000
Finite lived intangible assets |  | $ 40,000 |  |  |
Customer & supplier relationships |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Weighted average amortization lives |  | 13 years |  |  |
Gross carrying value |  | $ 9,851,000 |  | 3,761,000 |
Customer & supplier relationships | Stability Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  | 6,090,000 |  |
Customer & supplier relationships | Surgical Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  |  |  | 3,761,000
Non compete agreements |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Weighted average amortization lives |  | 4 years |  |  |
Gross carrying value |  | $ 1,080,000 |  | 0 |
Non compete agreements | Stability Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value |  |  | 1,080,000 |  |
Tradenames & trademarks |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value, indefinite lived |  | 1,838,000 |  | 1,008,000 |
Tradenames & trademarks | Stability Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value, indefinite lived |  |  | $ 830,000 |  |
Tradenames & trademarks | Surgical Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value, indefinite lived |  |  |  |  | 1,008,000
In process research & development |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value, indefinite lived |  | 25,000 |  | 25,000 |
In process research & development | Surgical Biologics, LLC |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value, indefinite lived |  |  |  |  | $ 25,000
Patents in process |  |  |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |  |  |
Gross carrying value, indefinite lived |  | $ 2,298,000 |  | $ 1,823,000 |

X
- Definition Royalty payment percentage on all commercial sales revenue from the licensed products. + References No definition available. + Details
Name: | mdxg_ContingentRoyaltyToBePaidToLicensor
Namespace Prefix: | mdxg_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Intangible Assets, Accumulated Amortization And Impairment Charges + References No definition available. + Details
Name: | mdxg_IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
Namespace Prefix: | mdxg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The maximum amount of time the entity has to obtain approval by the FDA to allow the sale of the product. + References No definition available. + Details
Name: | mdxg_PeriodOfApprovalMaximum
Namespace Prefix: | mdxg_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. + References No definition available. + Details
Name: | us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount before accumulated amortization of intangible assets, excluding goodwill. + References No definition available. + Details
Name: | us-gaap_IntangibleAssetsGrossExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 + Details
Name: | us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mdxg_StabilityBiologicsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=mdxg_SurgicalBiologicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_TradeNamesAndTrademarksMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |